Boundless Bio, Inc.BOLD
Price (close)
$2.66
Market cap
$59.8M
P/E
—
Revenue (TTM)
—
Net income
-$64.0M
Dividend yield
—
1-year total return
135.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What Boundless Bio, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net income | — | -$49.4M | -$65.4M | -$58.2M |
| Free cash flow | — | -$47.5M | -$63.4M | -$47.2M |
More on BOLD.
- Boundless Bio, Inc. summary
- Boundless Bio, Inc. financial statements
- Boundless Bio, Inc. key metrics
- Boundless Bio, Inc. health scores and style box
- Boundless Bio, Inc. earnings
- Boundless Bio, Inc. dividends
- Boundless Bio, Inc. valuation
- Boundless Bio, Inc. ownership and insiders
- Boundless Bio, Inc. peers
Figures from Boundless Bio, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.